publication . Article . 2007

The CHANT Trial

Lyden, P.D.; Shuaib, A.; Lees, K.R.; Davalos, A.; Davis, S.M.; Diener, H.-C.; Grotta, J.C.; Ashwood, T.J.; Hardemark, H.-G.; Svensson, H.H.; ...
Open Access
  • Published: 01 Jan 2007 Journal: Stroke, volume 38, pages 2,262-2,269 (issn: 0039-2499, eissn: 1524-4628, Copyright policy)
  • Publisher: Ovid Technologies (Wolters Kluwer Health)
  • Country: United Kingdom
<p><b>Background and Purpose:</b> NXY-059 is a free radical-trapping neuroprotectant developed for use in acute ischemic stroke. To facilitate prompt administration of treatment, potentially before neuroimaging, we investigated the safety of NXY-059 in patients with intracerebral hemorrhage (ICH).</p>\ud \ud <p><b>Methods:</b> We randomized 607 patients within 6 hours of acute ICH to receive 2270 mg intravenous NXY-059 over 1 hour and then up to 960 mg/h over 71 hours, or matching placebo, in addition to standard care. The primary outcome was safety: the mortality and the frequency of adverse events, and the change from ...
free text keywords: Advanced and Specialised Nursing, Clinical Neurology, Cardiology and Cardiovascular Medicine, Clinical trial, Modified Rankin Scale, Medicine, business.industry, business, Intracerebral hemorrhage, medicine.disease, Acute care, medicine.medical_specialty, Stroke, Anesthesia, Glasgow Coma Scale, Tolerability, Physical therapy, Placebo
Related Organizations
37 references, page 1 of 3

1. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study Preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415. [OpenAIRE]

2. Dennis MS, Burn JPS, Sandercock PAG, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796.

3. Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc Dis. 2004;17 Suppl 2:30 - 46.

4. Davalos A, Castillo J, Martinez-Vila E. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke. 1995;26:2233-2237.

5. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461- 467. [OpenAIRE]

6. Marler J, Tilley B, Lu M, Brott T, Lyden P, Grotta JC, Broderick J, Levine SR, Frankel M, Horowitz SH, Haley EC, Lewandowski C, Kwiatkowski T, Group Nr-PSS. Early stroke treatment associated with better outcome. Neurology. 2000;55:1649. [OpenAIRE]

7. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363:768.

8. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke. 2004; 35:e106. [OpenAIRE]

9. Butcher KS, Baird T, MacGregor L, Desmond P, Tress B, Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke. 2004;35:1879 -1885.

10. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993;262:689. [OpenAIRE]

11. Fantone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982; 107:397. [OpenAIRE]

12. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol. 1990;47:1245. [OpenAIRE]

13. Kuroda S, Tsuchidate R, Smith ML, Maples KR, Siesjo BK. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 1999;19:788.

14. Lapchak PA, Araujo DM, Song D, Wei J, Purdy R, Zivin J. Pharmacological effects of the spin trap agent disodium-[(tert-butylimino)- methyl]benzene-1,3-disulfonate N-oxide (Pi-by-no NXY-059) on intracerebral hemorrhage in a rabbit large clot thromboembolic stroke model: Combination studies with the thrombolytic tissue plasminogen activator (tPA). Stroke. 2002;33:1665.

15. Maples KR, Ma J, Zhang YK. Comparison of the radical trapping ability of pbn, s-pbn and nxy-059. Free Radic Res. 2001;34:417.

37 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2007

The CHANT Trial

Lyden, P.D.; Shuaib, A.; Lees, K.R.; Davalos, A.; Davis, S.M.; Diener, H.-C.; Grotta, J.C.; Ashwood, T.J.; Hardemark, H.-G.; Svensson, H.H.; ...